User profiles for B Burnett

Barrington Burnett

- Verified email at usuhs.edu - Cited by 4234

Brandon Burnett

- Verified email at weber.edu - Cited by 628

Type I interferon response and innate immune sensing of cancer

MB Fuertes, SR Woo, B Burnett, YX Fu… - Trends in …, 2013 - cell.com
Unexpectedly, many cancers appear to induce a spontaneous adaptive T cell response.
The presence of a T cell infiltrate has been linked to favorable clinical outcome in multiple …

The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies

CK Taylor, RM Levy, JC Elliott, BP Burnett - Nutrition reviews, 2009 - academic.oup.com
… Genistein increased the growth inhibition and apoptosis and reduced the adhesion and
migration of these cancer cell lines by inhibiting nuclear factor-kappa B (NF-κB) and Akt …

Recent advances in porphyrinic metal–organic frameworks: materials design, synthetic strategies, and emerging applications

BJ Burnett, PM Barron, W Choe - CrystEngComm, 2012 - pubs.rsc.org
Burnett was born and raised in Ogden, Utah. He received a BS degree in Chemistry from
Weber State University in 2009. As an undergraduate researcher, he worked with Prof. …

Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life.

…, CV Anderson, BM Burnett… - American journal …, 1995 - Am Soc Neuroradiology
… chiatric examinations, all subjects answered a questionnaire and were excluded if there was
a history of any of the following: (a) previous head injury causing loss of consciousness; (b) …

The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity

B Burnett, F Li, RN Pittman - Human molecular genetics, 2003 - academic.oup.com
The ubiquitin-proteasome pathway is critically involved in the pathology of neurodegenerative
diseases characterized by protein misfolding and aggregation. Data in the present study …

Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice

…, X Wang, DW Choe, M Polley, BG Burnett… - Journal of …, 2009 - Soc Neuroscience
B , Shown is a bar graph of the average EPC amplitude from CL and SMA mice (*p < 0.01, n
B , Shown are bar graphs of the average MEPC amplitude from CL and SMA pups (p = 0.38) …

[HTML][HTML] Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy

AM Avila, BG Burnett, AA Taye… - The Journal of …, 2007 - Am Soc Clin Investig
The inherited motor neuron disease spinal muscular atrophy (SMA) is caused by mutation of
the telomeric survival motor neuron 1 (SMN1) gene with retention of the centromeric SMN2 …

[HTML][HTML] Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis

VB Kraus, B Burnett, J Coindreau, S Cottrell… - Osteoarthritis and …, 2011 - Elsevier
OBJECTIVE: Osteoarthritis (OA) is a chronic and slowly progressive disease for which
biomarkers may be able to provide a more rapid indication of therapeutic responses to therapy …

Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C

G Landouré, AA Zdebik, TL Martinez, BG Burnett… - Nature …, 2010 - nature.com
Charcot-Marie-Tooth disease type 2C (CMT2C) is an autosomal dominant neuropathy
characterized by limb, diaphragm and laryngeal muscle weakness. Two unrelated families with …

Stepwise synthesis of metal–organic frameworks: replacement of structural organic linkers

BJ Burnett, PM Barron, C Hu… - Journal of the American …, 2011 - ACS Publications
We demonstrate how a single-crystal to single-crystal transformation resulting from bridging-linker
replacement is possible in extended 2D and 3D metal–organic frameworks (MOFs) by …